Severe Sporotrichosis Caused by Sporothrix brasiliensis: Antifungal Susceptibility and Clinical Outcomes

alcoholism amphotericin B antifungal susceptibility minimal inhibitory concentration sporotrichosis synergism

Journal

Journal of fungi (Basel, Switzerland)
ISSN: 2309-608X
Titre abrégé: J Fungi (Basel)
Pays: Switzerland
ID NLM: 101671827

Informations de publication

Date de publication:
28 Dec 2022
Historique:
received: 11 10 2022
revised: 13 12 2022
accepted: 20 12 2022
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 22 1 2023
Statut: epublish

Résumé

Itraconazole is the first choice for treating sporotrichosis. Amphotericin B is indicated for severe and disseminated forms. The aim of the study was to evaluate the antifungal susceptibility of

Identifiants

pubmed: 36675870
pii: jof9010049
doi: 10.3390/jof9010049
pmc: PMC9864959
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Coordenação de Aperfeicoamento de Pessoal de Nível Superior
ID : Finance Code 001
Organisme : National Council for Scientific and Technological Development
ID : CNPq 302796/2017-7
Organisme : Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
ID : FAPERJ E-26/202.527/2019 and 201441/2021
Organisme : Programa Jovens Pesquisadores - INI/Fiocruz
ID : [INI-003-FIO-19-2-7 and INI-003-FIO-19-2-13

Références

Infect Dis Ther. 2021 Mar;10(1):115-147
pubmed: 33523419
Clin Microbiol Infect. 2020 Nov;26(11):1464-1472
pubmed: 32562861
PLoS Negl Trop Dis. 2014 Sep 18;8(9):e3094
pubmed: 25233227
Clin Infect Dis. 2004 Feb 15;38(4):529-35
pubmed: 14765346
An Bras Dermatol. 2017 Sep-Oct;92(5):606-620
pubmed: 29166494
PLoS Negl Trop Dis. 2015 Dec 01;9(12):e0004190
pubmed: 26623643
J Antimicrob Chemother. 2003 Jul;52(1):1
pubmed: 12805255
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28739796
J Eur Acad Dermatol Venereol. 2015 Apr;29(4):719-24
pubmed: 25229626
JAC Antimicrob Resist. 2022 Jun 28;4(3):dlac067
pubmed: 35774069
Antimicrob Agents Chemother. 2008 Feb;52(2):732-4
pubmed: 18039919
PLoS One. 2015 May 01;10(5):e0125088
pubmed: 25933422
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2346-51
pubmed: 26833164
J Fungi (Basel). 2022 Apr 30;8(5):
pubmed: 35628725
Clin Infect Dis. 2009 Jun 15;48(12):1775-83
pubmed: 19441980
Drugs. 2013 Jun;73(9):919-34
pubmed: 23729001
AIDS Res Ther. 2015 May 07;12:16
pubmed: 25949269
Clin Infect Dis. 2010 Feb 1;50(3):291-322
pubmed: 20047480
Med Mycol. 2017 Jul 1;55(5):507-517
pubmed: 27771622
Clin Microbiol Rev. 2011 Oct;24(4):633-54
pubmed: 21976602
Cochrane Database Syst Rev. 2020 Apr 28;4:CD013594
pubmed: 32343003
Clin Microbiol Infect. 2009 Jul;15(7):651-5
pubmed: 19624508
Clin Infect Dis. 2007 Nov 15;45(10):1255-65
pubmed: 17968818
AIDS Care. 2019 Jan;31(1):35-40
pubmed: 30241440
Mem Inst Oswaldo Cruz. 2017 May;112(5):376-381
pubmed: 28443986
N Engl J Med. 2013 Apr 4;368(14):1291-1302
pubmed: 23550668

Auteurs

Vivian Fichman (V)

Laboratory of Clinical Research in Infectious Dermatology, Evandro Chagas National Institute of Infectious Diseases (INI), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-360, RJ, Brazil.

Fernando Almeida-Silva (F)

Laboratory of Mycology, Evandro Chagas National Institute of Infectious Diseases (INI), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-360, RJ, Brazil.

Dayvison Francis Saraiva Freitas (D)

Laboratory of Clinical Research in Infectious Dermatology, Evandro Chagas National Institute of Infectious Diseases (INI), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-360, RJ, Brazil.

Rosely Maria Zancopé-Oliveira (RM)

Laboratory of Mycology, Evandro Chagas National Institute of Infectious Diseases (INI), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-360, RJ, Brazil.

Maria Clara Gutierrez-Galhardo (MC)

Laboratory of Clinical Research in Infectious Dermatology, Evandro Chagas National Institute of Infectious Diseases (INI), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-360, RJ, Brazil.

Rodrigo Almeida-Paes (R)

Laboratory of Mycology, Evandro Chagas National Institute of Infectious Diseases (INI), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-360, RJ, Brazil.

Classifications MeSH